The Hollywood Secret: 10+ Celebrities Who Have Confirmed Using Ozempic And What They Said In 2024
The conversation surrounding Ozempic (semaglutide) has exploded across Hollywood, moving from hushed whispers to front-page headlines, and as of December 2025, more celebrities than ever are speaking out. This injectable medication, originally developed for managing Type 2 Diabetes, has become the go-to weight loss solution for many in the entertainment industry, but the public discourse in 2024 is no longer just about the dramatic results—it's about the side effects, the ethical debates, and the pressure to maintain an unattainable body standard. The transparency from these high-profile figures offers a rare, unfiltered look into the reality of using this powerful drug.
The latest wave of admissions and cautionary tales in 2024 has reshaped the narrative, with stars like Lizzo and Macy Gray adding their voices to the growing list of those who have used a GLP-1 Receptor Agonist. From those who found success to those who suffered severe complications, here is a comprehensive look at the celebrities who have confirmed their use and the details of their personal experiences with the "Hollywood weight loss" drug.
Confirmed Celebrity Users and Their Detailed Profiles
The following prominent figures have publicly confirmed their use of Ozempic, Wegovy, Mounjaro, or a similar GLP-1 drug, sharing a range of outcomes from positive transformations to serious health warnings. This list provides a snapshot of their career and their specific connection to the drug.
- Lizzo (Melissa Viviane Jefferson): An American singer, rapper, songwriter, and flutist, born April 27, 1988, known for her messages of body positivity and empowerment.
Ozempic Connection: Became one of the latest high-profile stars to speak openly about using semaglutide in late 2024, adding a complex layer to her long-standing advocacy for body acceptance. - Oprah Winfrey (Oprah Gail Winfrey): American talk show host, television producer, actress, author, and media proprietor, born January 29, 1954. She is a cultural icon best known for The Oprah Winfrey Show.
Ozempic Connection: Confirmed in late 2023/early 2024 that she was using a weight-loss drug, widely understood to be a GLP-1 medication, emphasizing it as a "tool" to manage her weight and health. - Kelly Clarkson (Kelly Brianne): American singer, songwriter, and television personality, born April 24, 1982, who rose to fame after winning the inaugural season of American Idol.
Ozempic Connection: Has been transparent about using a weight-loss medication prescribed by her doctor for health reasons, though she has not explicitly named Ozempic, she confirmed it was a GLP-1 drug. - Rebel Wilson (Rebel Melanie Elizabeth Wilson): Australian actress, comedian, and producer, born March 2, 1980, famous for roles in films like Pitch Perfect and Bridesmaids.
Ozempic Connection: Admitted to using the drug temporarily to support her weight loss journey, which was primarily motivated by fertility reasons, highlighting the intense pressure in Hollywood. - Amy Schumer (Amy Beth Schumer): American stand-up comedian, actress, writer, producer, and director, born June 1, 1981, known for her pointed, self-deprecating humor.
Ozempic Connection: Openly discussed trying the drug but stopped due to experiencing negative side effects, particularly feeling too sick to function, offering a cautionary perspective. - Macy Gray (Natalie Renée McIntyre): American R&B and soul singer, born September 6, 1967, known for her distinctive raspy voice.
Ozempic Connection: Shared a shocking 2024 experience about being hospitalized due to severe side effects from taking Ozempic for weight loss, a serious warning about the drug's potency. - Jon Gosselin (Jonathan Keith Gosselin): American former television personality, born April 1, 1977, best known for the reality show Jon & Kate Plus 8.
Ozempic Connection: Revealed in early 2024 that he began using semaglutide as part of a wellness program to focus on his health and working out.
The Science Behind the Craze: Semaglutide vs. Tirzepatide
The term "Ozempic" has become a catch-all phrase, but the reality is that several powerful medications are fueling the Hollywood weight loss phenomenon. These drugs belong to a class called GLP-1 Receptor Agonists (GLP-1 RAs), which mimic a naturally occurring incretin hormone called Glucagon-Like Peptide-1.
How GLP-1 Drugs Work to Promote Weight Loss
The mechanism of action for these injectable medications is threefold.
- Appetite Suppression: The drugs act on the brain's appetite centers, leading to a significant reduction in hunger and caloric intake.
- Slowing Gastric Emptying: They slow down the rate at which food leaves the stomach, creating a prolonged feeling of fullness (satiety). This is a primary cause of the common gastrointestinal side effects.
- Insulin Regulation: They stimulate the pancreas to release the right amount of insulin when blood sugar is high, which is why they were originally approved for Type 2 Diabetes.
The two main molecules dominating the market, and the ones celebrities are reportedly using, are Semaglutide and Tirzepatide.
- Semaglutide: This is the active ingredient in Ozempic (approved for diabetes) and Wegovy (approved for chronic weight management). Wegovy is simply a higher-dose formulation of the same molecule.
- Tirzepatide: This is the active ingredient in Mounjaro (approved for diabetes) and Zepbound (approved for chronic weight management). Tirzepatide is a dual-action drug, targeting both the GLP-1 receptor and the GIP (Glucose-dependent Insulinotropic Polypeptide) receptor, which is why it often shows even more significant weight loss results than semaglutide alone.
- Liraglutide: An older GLP-1 RA (marketed as Saxenda for weight loss) that has been largely overshadowed by the newer, more potent semaglutide and tirzepatide.
The Unflattering Reality: Side Effects and Ethical Debates of 2024
While the weight loss results are often dramatic, the celebrity discussion in 2024 has shifted to the significant, and sometimes severe, drawbacks of these medications. The glamor of rapid weight loss comes with a host of physical and ethical complications that have sparked a major cultural debate.
The Physical Toll: 'Ozempic Face' and 'Ozempic Gut'
Beyond the common initial side effects like nausea, vomiting, and diarrhea, the rapid weight loss can lead to specific, visible physical changes that have become buzzwords in Hollywood.
- Ozempic Face: This term refers to the hollowed, sunken appearance of the face that results from losing a significant amount of fat quickly. Dermatologists explain that the sudden loss of facial volume can make lines and wrinkles more visible, leading to a gaunt or aged look.
- Ozempic Gut/Stomach Issues: Due to the drug's effect of slowing gastric emptying, users often report chronic gastrointestinal disorders, including severe constipation, bloating, and in rare cases, a condition known as gastroparesis (stomach paralysis). Macy Gray's hospitalization in 2024 is a stark example of the potential severity of these side effects.
- Ozempic Butt: While less common, this term describes the sagging or deflated appearance of the gluteal area that can occur with extreme, rapid weight loss.
The Hollywood Ethical Quandary: Access and Body Standards
The proliferation of GLP-1 drugs among the wealthy and famous has ignited a serious ethical debate.
The core of the controversy centers on equity and access. Ozempic and Mounjaro were developed and approved to treat Type 2 Diabetes, a chronic disease that disproportionately affects lower-income communities. As celebrities and those seeking cosmetic weight loss drive up demand, a global shortage of semaglutide and tirzepatide has occurred, making it difficult for diabetic patients to access the medication they need for life-saving treatment.
Furthermore, critics argue that the "Ozempic craze" reinforces harmful, unattainable beauty standards in Hollywood. The drug's success seems to undermine the progress made by the Body Positivity Movement, suggesting that even for those who championed self-acceptance, extreme thinness remains the ultimate professional and personal goal. The sheer visibility of celebrity weight loss further pressures the general public, particularly young people, to pursue similar drastic measures, often without a medical necessity or doctor's supervision.
The candid discussions from stars like Amy Schumer, who quit the drug due to illness, and Rebel Wilson, who used it strictly as a temporary tool for fertility, are vital contributions to a more nuanced conversation. Their experiences serve as a necessary counterpoint to the dramatic before-and-after photos, reminding the public that these are powerful pharmaceutical agents with significant risks and ethical implications that extend far beyond the red carpet.
Detail Author:
- Name : Sean Hansen
- Username : beer.dylan
- Email : celine42@hudson.com
- Birthdate : 1990-03-07
- Address : 6300 Skyla Inlet Lamontbury, SD 83678
- Phone : 828.988.4569
- Company : Sanford and Sons
- Job : Metal-Refining Furnace Operator
- Bio : Dolorem voluptas aut excepturi. Est consequatur aut magni voluptate mollitia animi. Quasi magni voluptatum accusamus similique tempora possimus tempore.
Socials
instagram:
- url : https://instagram.com/torp2010
- username : torp2010
- bio : Dolores eaque enim quisquam aut. Vero dolorum dolorum et quas ab.
- followers : 6451
- following : 256
facebook:
- url : https://facebook.com/torp1985
- username : torp1985
- bio : Aut autem ab qui mollitia non dignissimos tempora.
- followers : 4829
- following : 1003
linkedin:
- url : https://linkedin.com/in/rowena.torp
- username : rowena.torp
- bio : Ratione voluptas enim ut.
- followers : 6476
- following : 2711
twitter:
- url : https://twitter.com/rowena_torp
- username : rowena_torp
- bio : Voluptates voluptate rerum rem ipsa et officia. Et nam possimus pariatur iste nesciunt aut.
- followers : 4323
- following : 2548
tiktok:
- url : https://tiktok.com/@rowena_dev
- username : rowena_dev
- bio : Eos laudantium velit consectetur impedit temporibus.
- followers : 3008
- following : 2781
